ARM (ARM) Financials

$221.29 +13.37 (+6.43%)

Closing price 05/13/2026 04:00 PM Eastern

Extended Trading

$214.06 -7.23 (-3.27%)

As of 05:41 AM Eastern

Annual Income Statements for ARM

This table shows ARM's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	3/31/2022	3/31/2023	3/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	549	524	306	792
Consolidated Net Income / (Loss)	549	524	306	792
Net Income / (Loss) Continuing Operations	676	524	306	792
Total Pre-Tax Income	786	671	212	720
Total Operating Income	633	671	111	831
Total Gross Profit	2,572	2,573	3,079	3,886
Total Revenue	2,703	2,679	3,233	4,007
Operating Revenue	2,703	2,679	3,233	4,007
Total Cost of Revenue	131	106	154	121
Operating Cost of Revenue	131	106	154	121
Total Operating Expenses	1,939	1,902	2,968	3,055
Selling, General & Admin Expense	897	762	983	984
Research & Development Expense	995	1,133	1,979	2,071
Restructuring Charge	26	7.00	6.00	0.00
Total Other Income / (Expense), net	153	0.00	101	-111
Interest & Investment Income	143	-3.00	90	-121
Other Income / (Expense), net	10	3.00	11	10
Income Tax Expense	110	147	-94	-72
Weighted Average Basic Shares Outstanding	1.03B	1.03B	1.03B	1.05B
Weighted Average Diluted Shares Outstanding	1.03B	1.03B	1.04B	1.06B
Weighted Average Basic & Diluted Shares Outstanding	-	-	1.04B	1.06B

No quarterly income statements for ARM are available.

This table details how cash moves in and out of ARM's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	3/31/2022	3/31/2023	3/31/2024	3/31/2025
Net Change in Cash & Equivalents	-210	550	369	162
Net Cash From Operating Activities	458	739	1,090	397
Net Cash From Continuing Operating Activities	458	739	1,090	397
Net Income / (Loss) Continuing Operations	549	524	306	792
Consolidated Net Income / (Loss)	549	524	306	792
Depreciation Expense	185	170	162	183
Non-Cash Adjustments To Reconcile Net Income	-229	92	755	654
Changes in Operating Assets and Liabilities, net	-47	-47	-133	-1,232
Net Cash From Investing Activities	-619	-138	-516	-35
Net Cash From Continuing Investing Activities	-619	-138	-516	-35
Purchase of Property, Plant & Equipment	-34	-64	-92	-219
Acquisitions	-41	-29	-51	-20
Purchase of Investments	-758	-1,126	-797	-737
Sale and/or Maturity of Investments	245	1,081	425	940
Other Investing Activities, net	-31	0.00	-1.00	1.00
Net Cash From Financing Activities	-32	-42	-208	-202
Net Cash From Continuing Financing Activities	-32	-42	-208	-202
Repayment of Debt	-2.00	-2.00	-10	-23
Other Financing Activities, net	-37	-40	-198	-179
Effect of Exchange Rate Changes	-17	-9.00	3.00	2.00
Cash Income Taxes Paid	141	157	187	149

No quarterly cash flow statements for ARM are available.

This table presents ARM's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2023	2024	2025
Period end date	3/31/2023	3/31/2024	3/31/2025
Total Assets	6,866	7,927	8,932
Total Current Assets	3,537	4,197	4,830
Cash & Equivalents	1,554	1,923	2,085
Short-Term Investments	661	1,000	740
Accounts Receivable	999	781	1,107
Prepaid Expenses	169	157	256
Other Current Assets	154	336	642
Plant, Property, & Equipment, net	185	215	394
Total Noncurrent Assets	3,144	3,515	3,708
Long-Term Investments	723	741	565
Goodwill	1,620	1,625	1,620
Intangible Assets	138	152	151
Noncurrent Deferred & Refundable Income Taxes	139	282	401
Other Noncurrent Operating Assets	524	475	971
Total Liabilities & Shareholders' Equity	6,866	7,927	8,932
Total Liabilities	2,815	2,632	2,093
Total Current Liabilities	1,363	1,505	929
Current Deferred Revenue	293	198	209
Current Deferred & Payable Income Tax Liabilities	162	147	124
Current Employee Benefit Liabilities	589	298	140
Other Current Liabilities	319	862	456
Total Noncurrent Liabilities	1,452	1,107	1,164
Noncurrent Deferred & Payable Income Tax Liabilities	262	135	41
Other Noncurrent Operating Liabilities	1,190	255	1,123
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	4,051	5,295	6,839
Total Preferred & Common Equity	4,051	5,295	6,839
Total Common Equity	4,051	5,295	6,839
Common Stock	1,218	2,173	2,924
Retained Earnings	2,457	2,751	3,543
Accumulated Other Comprehensive Income / (Loss)	376	371	372

This table presents ARM's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q4 2024
Period end date	3/31/2023	3/31/2024
Total Assets	6,866	7,927
Total Current Assets	3,537	4,197
Cash & Equivalents	1,554	1,923
Short-Term Investments	661	1,000
Accounts Receivable	999	781
Prepaid Expenses	169	157
Other Current Assets	154	336
Plant, Property, & Equipment, net	185	215
Total Noncurrent Assets	3,144	3,515
Long-Term Investments	723	741
Noncurrent Note & Lease Receivables	-	240
Goodwill	1,620	1,625
Intangible Assets	138	152
Noncurrent Deferred & Refundable Income Taxes	139	282
Other Noncurrent Operating Assets	524	475
Total Liabilities & Shareholders' Equity	6,866	7,927
Total Liabilities	2,815	2,632
Total Current Liabilities	1,363	1,505
Current Deferred Revenue	293	198
Current Deferred & Payable Income Tax Liabilities	162	147
Current Employee Benefit Liabilities	589	298
Other Current Liabilities	319	862
Total Noncurrent Liabilities	1,452	1,107
Noncurrent Deferred Revenue	-	717
Noncurrent Deferred & Payable Income Tax Liabilities	262	135
Other Noncurrent Operating Liabilities	1,190	255
Commitments & Contingencies	0.00	0.00
Total Equity & Noncontrolling Interests	4,051	5,295
Total Preferred & Common Equity	4,051	5,295
Total Common Equity	4,051	5,295
Common Stock	1,218	2,173
Retained Earnings	2,457	2,751
Accumulated Other Comprehensive Income / (Loss)	376	371

This table displays calculated financial ratios and metrics derived from ARM's official financial filings.

Metric	2022	2023	2024	2025
Period end date	3/31/2022	3/31/2023	3/31/2024	3/31/2025
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	-0.89%	20.68%	23.94%
EBITDA Growth	0.00%	1.93%	-66.35%	260.56%
EBIT Growth	0.00%	4.82%	-81.90%	589.34%
NOPAT Growth	0.00%	-3.76%	-69.46%	470.91%
Net Income Growth	0.00%	-4.55%	-41.60%	158.82%
EPS Growth	0.00%	-5.56%	-43.14%	0.00%
Operating Cash Flow Growth	0.00%	61.35%	47.50%	-63.58%
Free Cash Flow Firm Growth	0.00%	0.00%	35.82%	-133.91%
Invested Capital Growth	0.00%	0.00%	48.34%	108.90%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-
Gross Margin	95.15%	96.04%	95.24%	96.98%
EBITDA Margin	30.63%	31.50%	8.78%	25.56%
Operating Margin	23.42%	25.05%	3.43%	20.74%
EBIT Margin	23.79%	25.16%	3.77%	20.99%
Profit (Net Income) Margin	20.31%	19.56%	9.46%	19.77%
Tax Burden Percent	69.85%	78.09%	144.34%	110.00%
Interest Burden Percent	122.24%	99.55%	173.77%	85.61%
Effective Tax Rate	13.96%	21.88%	-44.25%	-10.00%
Return on Invested Capital (ROIC)	0.00%	94.20%	11.59%	35.85%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	94.21%	7.15%	39.32%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-68.33%	-5.04%	-22.79%
Return on Equity (ROE)	0.00%	25.87%	6.55%	13.05%
Cash Return on Invested Capital (CROIC)	0.00%	-105.80%	-27.34%	-34.66%
Operating Return on Assets (OROA)	0.00%	9.82%	1.65%	9.98%
Return on Assets (ROA)	0.00%	7.63%	4.14%	9.40%
Return on Common Equity (ROCE)	0.00%	25.87%	6.55%	13.05%
Return on Equity Simple (ROE_SIMPLE)	0.00%	12.94%	5.78%	11.58%
Net Operating Profit after Tax (NOPAT)	545	524	160	914
NOPAT Margin	20.15%	19.57%	4.95%	22.81%
Net Nonoperating Expense Percent (NNEP)	0.00%	-0.01%	4.43%	-3.47%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	13.37%
Cost of Revenue to Revenue	4.85%	3.96%	4.76%	3.02%
SG&A Expenses to Revenue	33.19%	28.44%	30.41%	24.56%
R&D to Revenue	36.81%	42.29%	61.21%	51.68%
Operating Expenses to Revenue	71.74%	71.00%	91.80%	76.24%
Earnings before Interest and Taxes (EBIT)	643	674	122	841
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	828	844	284	1,024
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	1.20	24.66	16.60
Price to Tangible Book Value (P/TBV)	0.00	2.12	37.11	22.40
Price to Revenue (P/Rev)	1.80	1.82	40.38	28.33
Price to Earnings (P/E)	8.87	9.29	426.64	143.33
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	11.27%	10.76%	0.23%	0.70%
Enterprise Value to Invested Capital (EV/IC)	0.00	1.74	76.86	31.93
Enterprise Value to Revenue (EV/Rev)	0.00	0.72	39.25	27.48
Enterprise Value to EBITDA (EV/EBITDA)	0.00	2.29	446.79	107.55
Enterprise Value to EBIT (EV/EBIT)	0.00	2.87	1,040.06	130.95
Enterprise Value to NOPAT (EV/NOPAT)	0.00	3.69	792.49	120.48
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	2.62	116.41	277.40
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00
Financial Leverage	0.00	-0.73	-0.70	-0.58
Leverage Ratio	0.00	1.69	1.58	1.39
Compound Leverage Factor	0.00	1.69	2.75	1.19
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	2.63	31.11	34.38
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-
Current Ratio	0.00	2.60	2.79	5.20
Quick Ratio	0.00	2.36	2.46	4.23
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-589	-378	-884
Operating Cash Flow to CapEx	1,347.06%	1,154.69%	1,184.78%	181.28%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-
Asset Turnover	0.00	0.39	0.44	0.48
Accounts Receivable Turnover	0.00	2.68	3.63	4.24
Inventory Turnover	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	14.48	16.17	13.16
Accounts Payable Turnover	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	136.11	100.48	85.99
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	136.11	100.48	85.99
Capital & Investment Metrics	-	-	-	-
Invested Capital	0.00	1,113	1,651	3,449
Invested Capital Turnover	0.00	4.81	2.34	1.57
Increase / (Decrease) in Invested Capital	0.00	1,113	538	1,798
Enterprise Value (EV)	0.00	1,933	126,888	110,128
Market Capitalization	4,871	4,871	130,552	113,518
Book Value per Share	$0.00	$3.95	$5.15	$6.57
Tangible Book Value per Share	$0.00	$2.24	$3.42	$4.87
Total Capital	0.00	4,051	5,295	6,839
Total Debt	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00
Net Debt	0.00	-2,938	-3,664	-3,390
Capital Expenditures (CapEx)	34	64	92	219
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-41	-231	1,076
Debt-free Net Working Capital (DFNWC)	0.00	2,174	2,692	3,901
Net Working Capital (NWC)	0.00	2,174	2,692	3,901
Net Nonoperating Expense (NNE)	-4.35	0.20	-146	122
Net Nonoperating Obligations (NNO)	0.00	-2,938	-3,644	-3,390
Total Depreciation and Amortization (D&A)	185	170	162	183
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-1.53%	-7.15%	26.85%
Debt-free Net Working Capital to Revenue	0.00%	81.15%	83.27%	97.35%
Net Working Capital to Revenue	0.00%	81.15%	83.27%	97.35%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.30	$0.00
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	1.03B	1.05B
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.29	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	1.04B	1.06B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	1.04B	1.06B
Normalized Net Operating Profit after Tax (NOPAT)	585	530	82	582
Normalized NOPAT Margin	21.65%	19.77%	2.53%	14.52%
Pre Tax Income Margin	29.08%	25.05%	6.56%	17.97%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-
Dividend Payout Ratio	7.83%	0.00%	0.00%	0.00%
Augmented Payout Ratio	7.83%	0.00%	0.00%	0.00%

No quarterly metrics and ratios for ARM are available.

Financials Breakdown Chart

Key Financial Trends

ARM Holdings plc (ARM) reported balance sheet figures for FY2023 and FY2024 (ending March 31). Below are the notable year-over-year trends based on the last two reported periods.

Cash & Equivalents increased to $1.923B in FY2024 from $1.554B in FY2023 (+ approximately 23.7%).
Short-Term Investments rose to $1.0B from $661M (+ approximately 51%).
Total Current Assets grew to $4.198B from $3.537B (+ approximately 18.7%).
Total Assets climbed to $7.927B from $6.867B (+ approximately 15.4%).
Total Equity increased to $5.295B from $4.051B (+ approximately 30.7%).
Common Stock rose to $2.173B from $1.218B, indicating new equity issuance (+ roughly $0.955B).
Noncurrent Liabilities declined to $1.107B from $1.452B (long-term leverage down ~24%).
Current Deferred Revenue decreased to $198M from $293M, reducing near-term liabilities (+ liquidity signal).
Noncurrent Deferred Revenue increased to $717M from $262M (+173%), reflecting more future revenue recognition (neutral impact on near-term liquidity).
Intangible Assets rose to $152M from $138M (+10%), indicating asset base growth (neutral impact).

05/14/26 05:42 AM ETAI Generated. May Contain Errors.

ARM Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ARM's fiscal year ends in March. Their fiscal year 2025 ended on March 31, 2025.

ARM's net income appears to be on an upward trend, with a most recent value of $792 million in 2025, rising from $549 million in 2022. The previous period was $306 million in 2024. Find out what analysts predict for ARM in the coming months.

ARM's total operating income in 2025 was $831 million, based on the following breakdown:

Total Gross Profit: $3.89 billion
Total Operating Expenses: $3.06 billion

Over the last 3 years, ARM's total revenue changed from $2.70 billion in 2022 to $4.01 billion in 2025, a change of 48.2%.

ARM's total liabilities were at $2.09 billion at the end of 2025, a 20.5% decrease from 2024, and a 25.6% decrease since 2023.

In the past 2 years, ARM's cash and equivalents has ranged from $1.55 billion in 2023 to $2.09 billion in 2025, and is currently $2.09 billion as of their latest financial filing in 2025.

Over the last 3 years, ARM's book value per share changed from 0.00 in 2022 to 6.57 in 2025, a change of 657.4%.

Related Companies

Financial statements for NASDAQ:ARM last updated on 8/6/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ARM (ARM) Financials

Financials Breakdown Chart

Key Financial Trends

ARM Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ARM (ARM) Financials

Annual Income Statements for ARM

Quarterly Income Statements for ARM

Annual Cash Flow Statements for ARM

Quarterly Cash Flow Statements for ARM

Annual Balance Sheets for ARM

Quarterly Balance Sheets for ARM

Annual Metrics And Ratios for ARM

Quarterly Metrics And Ratios for ARM

Financials Breakdown Chart

Key Financial Trends

ARM Financials - Frequently Asked Questions

When does ARM's financial year end?

How has ARM's net income changed over the last 3 years?

What is ARM's operating income?

How has ARM's revenue changed over the last 3 years?

How much debt does ARM have?

How much cash does ARM have?

How has ARM's book value per share changed over the last 3 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools